US Stock MarketDetailed Quotes
LVCLF ALGORAE PHARMACEUTICALS LTD
- 0.010
- 0.0000.00%
15min DelayTrading Sep 9 16:00 ET
17.34MMarket Cap-10275P/E (TTM)
0.000High0.000Low0Volume0.000Open0.010Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)1.69BShares0.01052wk High10.28P/B17.34MFloat Cap0.00052wk Low--Dividend TTM1.69BShs Float0.010Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
ALGORAE PHARMACEUTICALS LTD Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (FY)Jun 30, 2021 | (Q4)Jun 30, 2021 | (FY)Jun 30, 2020 | (Q4)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -80.34%808.41K | -80.34%808.41K | -3.01%4.11M | -3.01%4.11M | 162.92%4.24M | 162.92%4.24M | -45.62%1.61M | -45.62%1.61M | -39.59%2.96M | -39.59%2.96M |
| -Cash and cash equivalents | -80.34%808.41K | -80.34%808.41K | -3.01%4.11M | -3.01%4.11M | 170.18%4.24M | 170.18%4.24M | -47.08%1.57M | -47.08%1.57M | -39.59%2.96M | -39.59%2.96M |
| -Short-term investments | ---- | ---- | ---- | ---- | ---- | ---- | --43.3K | --43.3K | ---- | ---- |
| Receivables | -55.40%42.78K | -55.40%42.78K | 222.69%95.92K | 222.69%95.92K | 117.82%29.72K | 117.82%29.72K | -86.10%13.65K | -86.10%13.65K | -78.95%98.15K | -78.95%98.15K |
| -Accounts receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 246.27%75.5K | 246.27%75.5K |
| -Other receivables | -55.40%42.78K | -55.40%42.78K | 222.69%95.92K | 222.69%95.92K | 117.82%29.72K | 117.82%29.72K | -39.75%13.65K | -39.75%13.65K | -94.90%22.65K | -94.90%22.65K |
| Prepaid assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -54.12%9.77K | -54.12%9.77K |
| Other current assets | --2.34M | --2.34M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total current assets | -24.11%3.19M | -24.11%3.19M | -1.44%4.21M | -1.44%4.21M | 162.54%4.27M | 162.54%4.27M | -47.09%1.63M | -47.09%1.63M | -43.06%3.07M | -43.06%3.07M |
| Non current assets | ||||||||||
| Net PPE | ---- | ---- | -9.66%4.97K | -9.66%4.97K | -66.31%5.5K | -66.31%5.5K | -94.09%16.32K | -94.09%16.32K | 54.51%276.25K | 54.51%276.25K |
| -Gross PPE | ---- | ---- | -0.73%10.72K | -0.73%10.72K | -79.34%10.8K | -79.34%10.8K | -85.93%52.29K | -85.93%52.29K | -1.00%371.52K | -1.00%371.52K |
| -Accumulated depreciation | ---- | ---- | -8.53%-5.75K | -8.53%-5.75K | 85.26%-5.3K | 85.26%-5.3K | 62.25%-35.97K | 62.25%-35.97K | 51.52%-95.26K | 51.52%-95.26K |
| Investments and advances | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -50.64%42.04K | -50.64%42.04K |
| Total non current assets | --0 | --0 | -9.66%4.97K | -9.66%4.97K | -66.31%5.5K | -66.31%5.5K | -94.87%16.32K | -94.87%16.32K | -12.32%318.29K | -12.32%318.29K |
| Total assets | -24.20%3.19M | -24.20%3.19M | -1.45%4.21M | -1.45%4.21M | 160.27%4.27M | 160.27%4.27M | -51.57%1.64M | -51.57%1.64M | -41.12%3.39M | -41.12%3.39M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -56.55%172.87K | -56.55%172.87K | 102.17%397.88K | 102.17%397.88K | 16.07%196.8K | 16.07%196.8K | -14.30%169.56K | -14.30%169.56K | -87.25%197.85K | -87.25%197.85K |
| -accounts payable | -36.63%116.71K | -36.63%116.71K | 293.16%184.18K | 293.16%184.18K | 8.08%46.85K | 8.08%46.85K | -58.26%43.34K | -58.26%43.34K | -92.88%103.84K | -92.88%103.84K |
| -Other payable | -73.72%56.16K | -73.72%56.16K | 42.51%213.7K | 42.51%213.7K | 18.81%149.96K | 18.81%149.96K | 34.27%126.22K | 34.27%126.22K | 1.78%94K | 1.78%94K |
| Current provisions | -89.27%5.58K | -89.27%5.58K | --51.97K | --51.97K | ---- | ---- | ---- | ---- | ---- | ---- |
| Current debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --53.05K | --53.05K |
| -Current capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --53.05K | --53.05K |
| Current liabilities | -60.33%178.45K | -60.33%178.45K | 88.02%449.86K | 88.02%449.86K | -9.74%239.26K | -9.74%239.26K | -14.80%265.08K | -14.80%265.08K | -80.81%311.12K | -80.81%311.12K |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --201.6K | --201.6K |
| -Long term capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --201.6K | --201.6K |
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --201.6K | --201.6K |
| Total liabilities | -60.33%178.45K | -60.33%178.45K | 88.02%449.86K | 88.02%449.86K | -9.74%239.26K | -9.74%239.26K | -48.30%265.08K | -48.30%265.08K | -68.37%512.72K | -68.37%512.72K |
| Shareholders'equity | ||||||||||
| Share capital | 1.62%81.54M | 1.62%81.54M | 1.63%80.24M | 1.63%80.24M | 6.16%78.95M | 6.16%78.95M | 0.00%74.37M | 0.00%74.37M | 0.00%74.37M | 0.00%74.37M |
| -common stock | 1.62%81.54M | 1.62%81.54M | 1.63%80.24M | 1.63%80.24M | 6.16%78.95M | 6.16%78.95M | 0.00%74.37M | 0.00%74.37M | 0.00%74.37M | 0.00%74.37M |
| Retained earnings | 2.04%-79.08M | 2.04%-79.08M | -2.52%-80.73M | -2.52%-80.73M | -2.55%-78.74M | -2.55%-78.74M | -1.94%-76.79M | -1.94%-76.79M | -1.30%-75.33M | -1.30%-75.33M |
| Gains losses not affecting retained earnings | -86.90%557.07K | -86.90%557.07K | 11.01%4.25M | 11.01%4.25M | 0.96%3.83M | 0.96%3.83M | -1.06%3.79M | -1.06%3.79M | -7.07%3.83M | -7.07%3.83M |
| Total stockholders'equity | -19.88%3.01M | -19.88%3.01M | -6.76%3.76M | -6.76%3.76M | 192.99%4.03M | 192.99%4.03M | -52.16%1.38M | -52.16%1.38M | -30.45%2.88M | -30.45%2.88M |
| Total equity | -19.88%3.01M | -19.88%3.01M | -6.76%3.76M | -6.76%3.76M | 192.99%4.03M | 192.99%4.03M | -52.16%1.38M | -52.16%1.38M | -30.45%2.88M | -30.45%2.88M |
| Currency Unit | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data